Balance Sheet StrengthA high equity ratio and low debt-to-equity indicate durable financial resilience and low leverage. This supports capital allocation flexibility, reduces refinancing risk, and gives the company sustained ability to fund operations or investments through equity rather than costly debt over the next several quarters.

Multi-year Revenue ExpansionSustained revenue growth across multiple years reflects durable demand for products and successful market penetration. Even with a recent dip, the multi-year upward trend signals structural customer adoption and product-market fit that can underpin recovery and long-term top-line stability.

Strong Operating Cash ConversionHigh conversion of earnings into operating cash demonstrates quality of reported profits and internal cash generation capacity. This supports operational stability, funds working capital, and can finance investments or dividends without immediate reliance on external financing over the medium term.

Bears Say

Negative Free Cash FlowPersistently negative free cash flow driven by elevated capital expenditures can erode liquidity and force trade-offs between growth capex and shareholder returns. If capex remains high, the company may need to retain earnings or seek financing, which could constrain strategic flexibility over coming quarters.

Recent Revenue & EPS ContractionMaterial year-over-year declines in revenue and EPS suggest near-term demand weakness or margin pressures that have already impacted profitability. Such declines, if structural or prolonged, challenge operating leverage and require sustained management action to restore growth and earnings stability.

Profitability Margin PressureErosion in EBIT and net margins points to rising costs or pricing pressure that reduce earnings resiliency. Margin compression limits the company's ability to absorb shocks, fund reinvestment, or maintain returns to shareholders unless efficiency gains or pricing recovery are achieved over the medium term.

6568 FAQ

What was KNC Laboratories Co.,Ltd.’s price range in the past 12 months?

KNC Laboratories Co.,Ltd. lowest stock price was ¥957.00 and its highest was ¥1418.00 in the past 12 months.

What is KNC Laboratories Co.,Ltd.’s market cap?

KNC Laboratories Co.,Ltd.’s market cap is ¥9.86B.

When is KNC Laboratories Co.,Ltd.’s upcoming earnings report date?

KNC Laboratories Co.,Ltd.’s upcoming earnings report date is May 19, 2026 which is in 72 days.

How were KNC Laboratories Co.,Ltd.’s earnings last quarter?

KNC Laboratories Co.,Ltd. released its earnings results on Feb 13, 2026. The company reported ¥13.53 earnings per share for the quarter, beating the consensus estimate of N/A by ¥13.53.

Is KNC Laboratories Co.,Ltd. overvalued?

According to Wall Street analysts KNC Laboratories Co.,Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does KNC Laboratories Co.,Ltd. pay dividends?

KNC Laboratories Co.,Ltd. pays a Semiannually dividend of ¥17 which represents an annual dividend yield of 2.98%. See more information on KNC Laboratories Co.,Ltd. dividends here

What is KNC Laboratories Co.,Ltd.’s EPS estimate?

KNC Laboratories Co.,Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does KNC Laboratories Co.,Ltd. have?

KNC Laboratories Co.,Ltd. has 7,779,900 shares outstanding.

What happened to KNC Laboratories Co.,Ltd.’s price movement after its last earnings report?

KNC Laboratories Co.,Ltd. reported an EPS of ¥13.53 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.556%.

Which hedge fund is a major shareholder of KNC Laboratories Co.,Ltd.?

Currently, no hedge funds are holding shares in JP:6568

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

KNC Laboratories Co.,Ltd.

KNC Laboratories Co., Ltd. engages in the research, development, and production solutions of organic chemicals in Japan. The company offers products for use in the pharmaceutical, electronic-chemical, agrochemical, energy, and environment fields. It offers support services for drugs and functional chemicals. The company was incorporated in 1985 and is headquartered in Kobe, Japan.